Cannabis stocks soar 18% on promising Trump policy move
Cannabis companies experienced a remarkable Thursday as investors responded enthusiastically to reports that President Donald Trump plans to sign an executive order addressing federal marijuana …
Why Trulieve Cannabis Skyrocketed 14.1% Today
President Trump confirmed his administration is considering reclassifying marijuana to Schedule III. Trulieve stands out as one of the few companies operating with significant pre-tax earnings. The …
Trump’s giving cannabis stocks a lift—and the optimism may be justified
After many false starts, investors are once again betting that marijuana businesses are close to seeing federal restrictions ease.
As Trump Considers Signing a Cannabis Executive Order, Should You Buy the Dip in Tilray Stock?
Canadian cannabis stocks, including Tilray (TLRY), surged following reports that President Donald Trump could sign an executive order as soon as Monday reclassifying marijuana from a Schedule I drug like heroin to the less-restrictive Schedule III category,
Tilray stock soars on 3 major cannabis triggers today
Tilray Brands is riding a perfect storm of cannabis industry catalysts that sent the stock climbing on Monday, Dec. 15, 2025. The company finds itself at the intersection of Washington policy …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
This Stock Has Almost Tripled in 6 Months. Here’s What Investors Need to Watch Next
Now, it’s worth noting Stock Advisor’s total average return is 975 % — a market-crushing outperformance compared to 193% for the S&P 500. Don’t miss the latest top 10 list, available with Stock …
Cannabis use among seniors is up 46% as Trump moves to reclassify marijuana. Here’s what it could mean for pot stocks
This comes at a time when cannabis use among boomers is, well, booming. The number of Americans aged 65+ using cannabis for medical purposes rose from 4.8% in 2021 to 7% in 2023, …
Cannabis stocks give up gains after Trump order recommending to ease curbs on marijuana
Shares of some cannabis firms fell between 3% and 12% at Thursday’s close, erasing previous gains from the session, after U.S. President Donald Trump signed an executive order recommending the …
Trump’s Marijuana Order Spurs Stock Selloff, but Praise From Cannabis Executives
Cannabis stocks were mostly lower Thursday in volatile trading after President Trump signed an executive order directing the federal government to reclassify marijuana as a lower-risk drug. Shares of …
Cannabis Stocks Soar on Reports White House Plans to Reclassify Pot
Cannabis stocks surged on Friday following reports that President Trump plans to push to ease federal restrictions on marijuana. The White House is expected to direct federal agencies to reclassify …
Cronos Group (CRON) Goes 7.6% ‘High’ on Cannabis Expansion in Europe
Cronos Group jumped by 7.56 percent on Tuesday to finish at $2.69 apiece as investor sentiment was fueled by its cannabis expansion program with the full acquisition of a European company.
Cronos just bought Europe’s top cannabis producer — is this the catalyst investors have waited 5 years for?
Quick Read Cronos Group (CRON) acquired CanAdelaar for $67M upfront to enter Europe’s only regulated adult-use cannabis market. Cronos still holds $824M in cash after the deal. CanAdelaar operates a …
Tilray stock flirts with death cross amid Trump’s silence on cannabis reform
Tilray stock price has slumped in the past few weeks, moving from a high of $23.15 on October 9 to $7.20 today.
This stock-split stock is up 90% in the past 6 months: Is there more upside ahead?
Now, it’s worth noting Stock Advisor’s total average return is 1,001% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss out on the latest top 10 list, available when you …
Recent Comments